Find a Doctor

FH
Areas of Expertise

Francis J. Hornicek

Regents Of The University Of California
Orthopedics
Male
Practicing approx. 30 years

Bio

Francis Hornicek is an Orthopedics specialist in Los Angeles, California. He has been an author on 300 peer reviewed articles and participated in 1 clinical trial in the past 15 years. He is licensed to treat patients in CA, FL, and MA.

Areas of Expertise

Contact

100 Medical Plz
Suite 755
Los Angeles, CA 90095, US

310-206-2386

Latest Advances

Latest Advance
Study
  • Condition: Sarcomas
  • Journal: Cancer treatment reviews
  • Treatment Used: Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy
  • Number of Patients: 0
  • Published —
The study researched the outcomes of Chimeric antigen receptor T (CAR-T) cell immunotherapy in patients with sarcoma.
Latest Advance
Study
  • Condition: Cemented Endoprosthetic Reconstructions
  • Journal: The bone & joint journal
  • Treatment Used: Cross-Pin Fixation
  • Number of Patients: 51
  • Published —
This study presented the long-term outcomes of a custom-designed cross-pin fixation construct designed to minimize rotational stress and subsequent aseptic loosening in selected patients undergoing cemented endoprosthetic reconstructions, and examined the long-term survivorship and modes of failure when using this technique.
Latest Advance
Study
  • Condition: Sacral Chordoma
  • Journal: Journal of surgical oncology
  • Treatment Used: Low Dose Radiotherapy
  • Number of Patients: 193
  • Published —
This study reviewed the literature for the disease control and complications of the treatment of sacrococcygeal chordoma (a rare type of bone cancer that occurs in the lower spine) with emphasis on the effects of radiotherapy in surgically treated patients.
Latest Advance
Study
  • Condition: High-Risk Chordoma
  • Journal: International journal of radiation oncology, biology, physics
  • Treatment Used: Nilotinib Plus Radiation
  • Number of Patients: 23
  • Published —
This study identified the maximum tolerated dose (MTD), safety, and feasibility of nilotinib with radiation therapy (RT) as either preoperative or definitive treatment for patients with high-risk chordoma, malignant tumors arising from remnant notochordal tissue.

Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 6
  • Start Date: December 18, 2020
Use of Magnesium Oxide Biomaterial as a Bone Void Filler for Bone Voids or Defects Not Intrinsic to the Stability of Bony Structure

All Publications
View All

Publication
Study
  • Journal: Frontiers in oncology
  • Published —
Prognostic Significance of Cyclin E1 Expression in Patients With Chordoma: A Clinicopathological and Immunohistochemical Study.
Publication
Study
  • Journal: Cell proliferation
  • Published —
T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma.

Contact

100 Medical Plz
Suite 755
Los Angeles, CA 90095, US

310-206-2386

Credentials

  • Graduate InstitutionUniversity Of Pittsburgh School Of Medicine
    1991
  • Licenses
    Orthopaedic Surgery in CA
  • Board Certifications
    Orthopedic Surgery

Insurance

Contact them to find out if they accept your insurance plan.